USD
EUR
GBP
CAD
AUD
CHF
HKD
JPY
RUB
BRL
CLP
NOK
DKK
SEK
KRW
ILS
MXN
CNY
SAR
SGD
NZD
ARS
INR
COP
AED
Home
Products
Peptides
Nootropics
Steriods
Sarms
Custom synthesis
Others
About Us
About Us
Sitemap
FAQ
Blog
News
Download
Contact Us
Home > Company News
Company News
Vamorolone, a new drug in development

Vamorolone, a new drug in development

Oct 27, 2023

10-272023

Chemical Name: Vamorolone
Molecular Formula: C22H28O4
Formula Weight: 356.46
CAS No.: 13209-41-1
Lemon Tek: A Fresh Approach to Consuming Magic Mushrooms

Lemon Tek: A Fresh Approach to Consuming Magic Mushrooms

Oct 08, 2023

10-082023

A biotech that developed "psychedelics LSD " has seen its market value evaporate by 64%.

A biotech that developed "psychedelics LSD " has seen its market value evaporate by 64%.

Sep 17, 2023

09-172023

"Instant Sleep" or Health Red Light Signal! Pitolisant might be able to pull patients with narcolepsy out of the abyss of deep sleep

"Instant Sleep" or Health Red Light Signal! Pitolisant might be able to pull patients with narcolepsy out of the abyss of deep sleep

Sep 15, 2023

09-152023

Pitolisant cas: 903576-44-3 is a psychotropic drug
Triptorelin (CAS number: 140194-24-7) crizotinib

Triptorelin (CAS number: 140194-24-7) crizotinib

Sep 07, 2023

09-072023

CAS: 2023788-19-2 Tirzepatide

CAS: 2023788-19-2 Tirzepatide

Sep 01, 2023

09-012023

Purity (HPLC) ≥95.0%
Single impurity≤2%
Peptide content≥75.0%
Amino Acid Composition≤±15%
Bacterial Endotoxins≤50EU/mg
Vacuum-packed with aluminum foil bag or transparent bag. 10mg,50mg,100mg,1g,10g, 50g per package with icebag. Or according to your request.
Storage:Cool dry place( Store at -20°C, away from the light)
Remark:For Research Use Only. Not for human use.
Sequence(3-letter code)
H-Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Sequence(1-letter code)
Y-Aib-EGTFTSDYSI-Aib-LDKIAQK（diacid-gamma-Glu-(AEEA)2）AFVQWLIAGGPSSGAPPPS-NH2
Otsuka Pharmaceutical's (Otsuka) ponatinib tablet (ponatinib) marketing application was accepted by the State Drug Administration.

Otsuka Pharmaceutical's (Otsuka) ponatinib tablet (ponatinib) marketing application was accepted by the State Drug Administration.

May 12, 2023

05-122023

Name: ponatinib
CAS: 943319-70-8
Voxelotor, a drug for sickle cell disease

Voxelotor, a drug for sickle cell disease

May 10, 2023

05-102023

Voxelotor, a drug for sickle cell disease
Name: Voxelotor
CAS: 1446321-46-5
Originating company: Global Blood Therapeutics
Indication: Sickle cell disease
NASH Research Update│Resmetirom Receives Breakthrough Therapy Designation from FDA

NASH Research Update│Resmetirom Receives Breakthrough Therapy Designation from FDA

May 10, 2023

05-102023

NASH Research Update│Resmetirom Receives Breakthrough Therapy Designation from FDA
NASH treatment drug hits high note: Resmetirom Phase III progress excellent

NASH treatment drug hits high note: Resmetirom Phase III progress excellent

May 09, 2023

05-092023

NASH treatment drug hits high note: Resmetirom Phase III progress excellent
 12345 page: Go